WA
RVMD icon

Waddell & Associates’s Revolution Medicines RVMD Stock Holding History

Waddell & Associates’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+1,193
New +$174K 0.01% 489

Other funds holding RVMD

CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
APM
a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Waddell & Associates's RVMD Position: Q2 2026 in Review

Waddell & Associates opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,193 shares worth $223K. The stake represents 0.01% of the portfolio and ranks #489 among its holdings.

154 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Waddell & Associates held 1,193 shares of Revolution Medicines worth $223K as of Q2 2026.
  • Revolution Medicines was a new Waddell & Associates position in Q2 2026.
  • Revolution Medicines made up 0.01% of Waddell & Associates's portfolio in Q2 2026, its #489 holding.
  • 154 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.